Preliminary	0	10
X	12	12
-	13	13
ray	14	16
crystallographic	18	33
analysis	35	42
of	44	45
β	47	47
-	48	48
carbonic	49	56
anhydrase	58	66
psCA3	68	72
from	74	77
Pseudomonas	79	89
aeruginosa	91	100
.	101	101

Pseudomonas	103	113
aeruginosa	115	124
is	126	127
a	129	129
Gram	131	134
-	135	135
negative	136	143
bacterium	145	153
that	155	158
causes	160	165
life	167	170
-	171	171
threatening	172	182
infections	184	193
in	195	196
susceptible	198	208
individuals	210	220
and	222	224
is	226	227
resistant	229	237
to	239	240
most	242	245
clinically	247	256
available	258	266
antimicrobials	268	281
.	282	282

Genomic	284	290
and	292	294
proteomic	296	304
studies	306	312
have	314	317
identified	319	328
three	330	334
genes	336	340
,	341	341
pa0102	343	348
,	349	349
pa2053	351	356
and	358	360
pa4676	362	367
,	368	368
in	370	371
P	373	373
.	374	374
aeruginosa	376	385
PAO1	387	390
encoding	392	399
three	401	405
functional	407	416
β	418	418
-	419	419
carbonic	420	427
anhydrases	429	438
(	440	440
β	441	441
-	442	442
CAs	443	445
)	446	446
:	447	447
psCA1	449	453
,	454	454
psCA2	456	460
and	462	464
psCA3	466	470
,	471	471
respectively	473	484
.	485	485

These	487	491
β	493	493
-	494	494
CAs	495	497
could	499	503
serve	505	509
as	511	512
novel	514	518
antimicrobial	520	532
drug	534	537
targets	539	545
for	547	549
this	551	554
pathogen	556	563
.	564	564

X	566	566
-	567	567
ray	568	570
crystallographic	572	587
structural	589	598
studies	600	606
have	608	611
been	613	616
initiated	618	626
to	628	629
characterize	631	642
the	644	646
structure	648	656
and	658	660
function	662	669
of	671	672
these	674	678
proteins	680	687
.	688	688

This	690	693
communication	695	707
describes	709	717
the	719	721
production	723	732
of	734	735
two	737	739
crystal	741	747
forms	749	753
(	755	755
A	756	756
and	758	760
B	762	762
)	763	763
of	765	766
β	768	768
-	769	769
CA	770	771
psCA3	773	777
.	778	778

Form	780	783
A	785	785
diffracted	787	796
to	798	799
a	801	801
resolution	803	812
of	814	815
2	817	817
.	818	818
9	819	819
Å	821	821
;	822	822
it	824	825
belonged	827	834
to	836	837
space	839	843
group	845	849
P212121	851	857
,	858	858
with	860	863
unit	865	868
-	869	869
cell	870	873
parameters	875	884
a	886	886
=	888	888
81	890	891
.	892	892
9	893	893
,	894	894
b	896	896
=	898	898
84	900	901
.	902	902
9	903	903
,	904	904
c	906	906
=	908	908
124	910	912
.	913	913
2	914	914
Å	916	916
,	917	917
and	919	921
had	923	925
a	927	927
calculated	929	938
Matthews	940	947
coefficient	949	959
of	961	962
2	964	964
.	965	965
23	966	967
Å³	969	970
Da	972	973
⁻	974	974
¹	975	975
assuming	977	984
four	986	989
molecules	991	999
in	1001	1002
the	1004	1006
crystallographic	1008	1023
asymmetric	1025	1034
unit	1036	1039
.	1040	1040

Form	1042	1045
B	1047	1047
diffracted	1049	1058
to	1060	1061
a	1063	1063
resolution	1065	1074
of	1076	1077
3	1079	1079
.	1080	1080
0	1081	1081
Å	1083	1083
;	1084	1084
it	1086	1087
belonged	1089	1096
to	1098	1099
space	1101	1105
group	1107	1111
P21212	1113	1118
,	1119	1119
with	1121	1124
unit	1126	1129
-	1130	1130
cell	1131	1134
parameters	1136	1145
a	1147	1147
=	1149	1149
69	1151	1152
.	1153	1153
9	1154	1154
,	1155	1155
b	1157	1157
=	1159	1159
77	1161	1162
.	1163	1163
7	1164	1164
,	1165	1165
c	1167	1167
=	1169	1169
88	1171	1172
.	1173	1173
5	1174	1174
Å	1176	1176
,	1177	1177
and	1179	1181
had	1183	1185
a	1187	1187
calculated	1189	1198
Matthews	1200	1207
coefficient	1209	1219
of	1221	1222
2	1224	1224
.	1225	1225
48	1226	1227
Å³	1229	1230
Da	1232	1233
⁻	1234	1234
¹	1235	1235
assuming	1237	1244
two	1246	1248
molecules	1250	1258
in	1260	1261
the	1263	1265
crystallographic	1267	1282
asymmetric	1284	1293
unit	1295	1298
.	1299	1299

Preliminary	1301	1311
molecular	1313	1321
-	1322	1322
replacement	1323	1333
solutions	1335	1343
have	1345	1348
been	1350	1353
determined	1355	1364
with	1366	1369
the	1371	1373
PHENIX	1375	1380
AutoMR	1382	1387
wizard	1389	1394
and	1396	1398
refinement	1400	1409
of	1411	1412
both	1414	1417
crystal	1419	1425
forms	1427	1431
is	1433	1434
currently	1436	1444
in	1446	1447
progress	1449	1456
.	1457	1457
